Patent Assignment
Reel/Frame 012946/0018
Security Agreement
Recorded: 2002-06-03
Pages: 10
Assignor
INFIGEN, INC.
Executed: 2002-01-31
Assignee
WISCONSIN DEPARTMENT OF COMMERCE
201 WEST WASHINGTON AVENUE, BUREAU OF BUSINESS FINANCE, MADISON, WISCONSIN, 53707
Covered Properties
(21)
Synthetic Bovine Parainfluenza Viral Proteins
Patent:
4,847,081 →
Application:
07/014,499 →
Multiplying Bovine Embryos
Patent:
4,994,384 →
Application:
07/113,791 →
In Vitro Culture of Bovine Embryos
Patent:
5,213,979 →
Application:
07/139,887 →
Sex-Associated Membrane Antibodies and Their Use for Inccreasing the Probability That Offspring Will Be of a Desired Sex
Patent:
5,021,244 →
Application:
07/351,642 →
Bovine Embryo Medium
Patent:
5,096,822 →
Application:
07/558,969 →
Bovine Nuclear Transplantation
Patent:
5,057,420 →
Application:
07/599,256 →
Cryopreservation Process for Direct Transfer of Embryos
Patent:
5,160,312 →
Application:
07/651,458 →
Sex-Associated Membrane Proteins and Methods for Increasing the Probability That Offspring Will Be of a Desired Sex
Patent:
5,346,990 →
Application:
07/667,974 →
Parthenogenic Oocyte Activation
Patent:
5,496,720 →
Application:
08/016,703 →
Method of Cloning Bovine Embryos
Patent:
5,453,366 →
Application:
08/031,815 →
Gain or Loss Compensation Circuit for Telephone Lines
Patent:
5,347,544 →
Application:
08/056,412 →
Enhanced Gene Expression in Response to Lactation Signals
Patent:
5,320,952 →
Application:
08/071,594 →
Sex-Associated Membrane Proteins and Methods for Increasing the Probability That Offspring Will Be of a Desired Sex
Patent:
5,439,362 →
Application:
08/280,637 →
Culture of Totipotent Embryonic Inner Cell Mass Cells and Production of Bovine Animals
Patent:
6,107,543 →
Application:
08/348,769 →
Parthenogenic Bovine Oocyte Activation
Patent:
5,843,754 →
Application:
08/473,794 →
Methods for Determining Antibodies Specific for Sex Associated Sperm Membrane Proteins
Patent:
5,660,997 →
Application:
08/486,593 →
Parthenogenic Oocyte Activation
Patent:
6,194,202 →
Application:
08/610,744 →
Screening for the Molecular Defect Causing Spider Lamb Syndrome in Sheep
Patent:
6,306,591 →
Application:
09/099,749 →
Parthenogenic Oocyte Activation
Patent:
6,077,710 →
Application:
09/176,395 →
Method of Cloning Porcine Animals
Patent:
6,258,998 →
Application:
09/199,138 →
Method of Cloning Bovines Using Reprogrammed Non-Embryonic Bovine Cells
Patent:
6,011,197 →
Application:
09/239,922 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Nov 13, 2000
From: TELTREND, INC., A CORPORATION OF DELAWARE
To: LASALLE BANK NATIONAL ASSOCIATION (AS AGENT)
Reel/Frame 011245/0698 →
Security Interest
Feb 20, 2002
From: HANCOCK LIFE INSURANCE COMPANY; INVESTORS PARTNER LIFE INSURANCE COMPANY; MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY; MASSMUTUAL CORPORATE VALUE PARTNERS, LTD.
To: INFIGEN, INC.
Reel/Frame 012946/0009 →
Release of Security Interest
Sep 9, 2004
From: WISCONSIN DEPARTMENT OF COMMERCE
To: INFIGEN, INC.
Reel/Frame 015098/0332 →
Grant of a Security Interest in Grantor's (Debtor'
Feb 27, 2006
From: PHARMING GROUP N.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 017223/0001 →
License
Mar 2, 2006
From: INFIGEN, INC.
To: PHARMING GROUP N.V.
Reel/Frame 017240/0454 →
Release of Security Interest
Feb 23, 2010
From: PHARMING GROUP N.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 023973/0415 →
Corrective Assignment to Correct the Nature of Conveyance, Assignor and Assignee Previously Recorded on Reel 023973 Frame 0415. Assignor(S) Hereby Confirms the Release of Security Interest.
Mar 10, 2010
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: PHARMING GROUP N.V.
Reel/Frame 024079/0924 →
Assignment of Assignor's Interest
May 20, 2010
From: INFIGEN, INC.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 024411/0642 →
Assignment of Assignor's Interest
Aug 12, 2010
From: ADVANCED CELL TECHNOLOGY, INC.
To: PHARMING TECHNOLOGY B.V.
Reel/Frame 024823/0610 →
Assignment of Assignor's Interest
Apr 4, 2011
From: INFIGEN, INC.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 026069/0529 →
Assignment of Assignor's Interest
Apr 4, 2011
From: INFIGEN, INC.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 026069/0838 →
Assignment of Assignor's Interest
Apr 25, 2011
From: INFIGEN, INC.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 026183/0739 →
Assignment of Assignor's Interest
May 5, 2011
From: INFIGEN, INC.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 026232/0950 →
Assignment of Assignor's Interest
May 10, 2011
From: PHARMING TECHNOLOGY B.V.
To: PHARMING INTELLECTUAL PROPERTY B.V.
Reel/Frame 026251/0989 →
Security Agreement
Jan 25, 2013
From: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
To: CAMOFI MASTER LDC; CAMHZN MASTER LDC
Reel/Frame 029698/0001 →
Release of Security Interest
Nov 24, 2014
From: CAMOFI MASTER LDC; CAMHZN MASTER LDC
To: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
Reel/Frame 034421/0863 →
Security Interest
Dec 7, 2016
From: PHARMING GROUP N.V.
To: SILICON VALLEY BANK
Reel/Frame 040594/0031 →
Security Interest
Dec 7, 2016
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: SILICON VALLEY BANK
Reel/Frame 040839/0865 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING GROUP N.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0051 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →